1Memon A,Zawadzki Z A.Pleural effusions[J].Curr Probl Cancer,1981,5(8):3-30.
2Jones E Y,Stuart D I,Walker N P.Structure of tumor necrosis factor[J].Nature,1989,338 (3):225-228.
3Trape J,Molina R,Sant F,Clinical valuation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serour effusions[J].Tumor Biol,2004,25 (5 -6):276-281.
4Tsui-Lien Hung,Fen-Fen Chen,Jacquline M,et al.Clinical evaluation of HER-2/neu protein in malignant pleural effusion associated lung adenocarcinoma and as a tumor mark in pleural effusion diagnosis[J].Clinical Cancer Research,2003,9 (7):2605 -2612.
4Braunschweig R, Yah P, Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and etiological exam-ination. Diagn Cytopathol, 2001,24(3):174-180.
5Coogan CL. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder. Urology ,2004, 63 (4) :786 -790.
6Xiaoyan Wang . Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis Breast Cancer Res. 2005; 7(1) :145 -155.
7Simon R. , Nocito A. , Hubscher T. et al. Patterns of her-2/neu ampli- fication and overexpression in primary and metastatic breast cancer. J. Natl. Cancer Inst. (Bethesda), 2001, 93:1141 - 1146.
8Tsui-Lien Hung, Fen-Fen Chen, Jacqueline M. et al. Clinical Evaluation of HER-2/neu Protein in Malignant Pleural Effusion-Associated Lung Adenocarcinoma and as a Tumor Marker in Pleural Effusion Diagnosis. Clinical Cancer Research. 2003, 9(7) :2605 -2612.
9Goto M, Noguchi Y, Koyama H, et al. Diagnostic value of adenosine deaminase in tuberculosis pleural effusion: a meta- analysis[J]. Ann Clin Bioehem,2003,40(4) :374-381.
10Neves D D, Dias R M, Cunha A J. Predictive model for the diagnosis of tuberculous pleural effusion[J]. Braz J Infect Dis, 2007,11(1):83 -88.
